Commodore Capital LP

Holdings History for KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)

Symbol: KALV on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2023		-0.32%	$0	0	-312,553	-100%	$15.12	Q3 2023
30 Jun 2023	0.32%	0%	$2,812,977	312,553	0		$9.00	Q2 2023
31 Mar 2023	0.37%	0%	$2,456,667	312,553	0		$7.86	Q1 2023
31 Dec 2022	0.32%	0%	$2,113,000	312,553	0		$6.76	Q4 2022
30 Sep 2022	0.75%	0%	$4,535,000	312,553	0		$14.51	Q3 2022
30 Jun 2022	0.68%	0%	$3,076,000	312,553	0		$9.84	Q2 2022
31 Mar 2022	1%	0%	$4,607,000	312,553	0		$14.74	Q1 2022
31 Dec 2021	0.96%	0%	$4,135,000	312,553	0		$13.23	Q4 2021
30 Sep 2021	1.4%	+0.4%	$5,454,000	312,553	+85,882	+38%	$17.45	Q3 2021
30 Jun 2021	1.9%	+0.1%	$5,431,000	226,671	+12,204	+5.7%	$23.96	Q2 2021
31 Mar 2021	2.2%	+2.2%	$5,510,000	214,467	+214,467	NEW	$25.69	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.